Teva Pharmaceuticals @TevaUSA
Cory Wohlbach explains how #biosimilars have the potential to reduce costs for patients and how patient safety is always a top priority. #MeetOurExpert https://t.co/Cw67oIdJvW https://t.co/hB3JppkQst — PolitiTweet.org
Created
Fri Jan 22 14:00:26 +0000 2021
Likes
5
Retweets
1
Source
Salesforce - Social Studio
View Raw Data
JSON DataView on Twitter
Likely AvailableTeva Pharmaceuticals @TevaUSA
Cory Wohlbach explains how #biosimilars have the potential to reduce costs for patients and how patient safety is always a top priority. #MeetOurExpert https://t.co/Cw67oIdJvW https://t.co/hB3JppkQst — PolitiTweet.org